Primary Characterstics
Meglumine is also known as Dimeglumine. Meglumine gadopentetate, Meglumine gadopentetate, Meglumine gadopentetate, Meglumine gadopentetate, Meglumine gadopentetate are the derivatives of MeglumineMeglumine is also known as Dimeglumine. Meglumine gadopentetate, Meglumine gadopentetate, Meglumine gadopentetate, Meglumine gadopentetate, Meglumine gadopentetate are the derivatives of Meglumine It is of Synthetic origin and belongs to Methylglucamine sodium. It belongs to Radiopaque Agents and Diagnostic Aids pharmacological group.The Molecular Weight of Meglumine is 195.20.
It is weakly alkaline drug, 10.55% solution of the drug is isotonic.
Side Effects
The severe or irreversible adverse effects of Meglumine, which give rise to further complications include Pancreatitis, Impaired renal function, Hyperthyroidism.
Meglumine produces potentially life-threatening effects which include Anaphylactoid reactions, Ventricular fibrillation, Pulmonary edema, Cardiac arrhythmias, Angioneurotic edema. which are responsible for the discontinuation of Meglumine therapy.
The signs and symptoms that are produced after the acute overdosage of Meglumine include Bradycardia, Hypotension, Anaphylactoid reactions, Pyrexia, Renal failure, Tremor.
The symptomatic adverse reactions produced by Meglumine are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Nausea, Vomiting, Diarrhea, Fever, Abdominal pain, Chills, Rashes, Urticaria, Colitis, Itching, Hypotension, Flushing, Muscle weakness, Nausea and vomiting, Sneezing, Altered taste sensations, Faintness, Hypertension, Nodular goitre, Enteritis.